Cancer

18 results.

December 21, 2017 10 highlights: A look back at 2017

With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…

October 12, 2017 A Catalyst for combating cancer

Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers

By Dr. Peter Jones and Dr. Steve Baylin
…

October 12, 2017 Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…

May 15, 2017 Dr. Stephen Baylin becomes third VARI-affiliated scientist to be elected to National Academy of Sciences

VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences…

May 15, 2017 VARI cancer researcher elected to National Academy of Sciences

GRAND RAPIDS, Mich. (May 15, 2017) — Stephen Baylin, M.D., Director’s Scholar and professor in the Center of Epigenetics at

March 7, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial

GRAND RAPIDS, Mich. (March 7,…

February 3, 2017 In their own words: The most exciting advances in cancer research

In honor of World Cancer Day on Saturday, we asked our scientists and collaborators a simple question—what do you think is…

October 10, 2016 Combinations and collaborations in the fight against cancer: An interview with Dr. Feyruz Rassool and Dr. Stephen Baylin

What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be a more effective…